Lewis L. Smith

4.9k total citations
107 papers, 3.8k citations indexed

About

Lewis L. Smith is a scholar working on Surgery, Molecular Biology and Pharmacology. According to data from OpenAlex, Lewis L. Smith has authored 107 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Surgery, 37 papers in Molecular Biology and 28 papers in Pharmacology. Recurrent topics in Lewis L. Smith's work include Paraquat toxicity studies and treatments (37 papers), Estrogen and related hormone effects (22 papers) and Pharmacogenetics and Drug Metabolism (13 papers). Lewis L. Smith is often cited by papers focused on Paraquat toxicity studies and treatments (37 papers), Estrogen and related hormone effects (22 papers) and Pharmacogenetics and Drug Metabolism (13 papers). Lewis L. Smith collaborates with scholars based in United Kingdom, United States and Sweden. Lewis L. Smith's co-authors include I. Wyatt, Michael S. Rose, Gerald M. Cohen, Edward A. Lock, Ian N.H. White, Peter L. Keeling, Francesco De Matteis, Elizabeth A. Martin, Adrian Davies and W. McLean Provan and has published in prestigious journals such as Nature, PLoS ONE and Environmental Health Perspectives.

In The Last Decade

Lewis L. Smith

107 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lewis L. Smith United Kingdom 36 1.6k 1.2k 714 666 489 107 3.8k
Dean J. Tuma United States 51 2.5k 1.6× 714 0.6× 235 0.3× 445 0.7× 146 0.3× 261 8.3k
Hideki Mori Japan 36 1.7k 1.1× 441 0.4× 229 0.3× 385 0.6× 583 1.2× 190 4.3k
Naoki Yoshimi Japan 37 2.0k 1.3× 513 0.4× 357 0.5× 236 0.4× 678 1.4× 213 4.8k
Yoichi Konishi Japan 32 1.7k 1.1× 552 0.5× 302 0.4× 224 0.3× 155 0.3× 218 3.9k
Zhen Jiang China 25 2.5k 1.6× 545 0.5× 182 0.3× 268 0.4× 464 0.9× 49 6.4k
Kimihiko Satoh Japan 31 5.5k 3.5× 305 0.3× 389 0.5× 757 1.1× 420 0.9× 105 7.3k
Hideki Wanibuchi Japan 40 2.7k 1.7× 729 0.6× 261 0.4× 337 0.5× 373 0.8× 305 6.2k
Igor N. Zelko United States 20 1.7k 1.1× 258 0.2× 774 1.1× 1.4k 2.1× 193 0.4× 36 4.4k
Udayan Apte United States 44 2.3k 1.4× 1.1k 0.9× 261 0.4× 951 1.4× 163 0.3× 109 5.5k
Bhagavatula Moorthy United States 35 1.3k 0.8× 335 0.3× 273 0.4× 741 1.1× 205 0.4× 152 4.2k

Countries citing papers authored by Lewis L. Smith

Since Specialization
Citations

This map shows the geographic impact of Lewis L. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lewis L. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lewis L. Smith more than expected).

Fields of papers citing papers by Lewis L. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lewis L. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lewis L. Smith. The network helps show where Lewis L. Smith may publish in the future.

Co-authorship network of co-authors of Lewis L. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Lewis L. Smith. A scholar is included among the top collaborators of Lewis L. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lewis L. Smith. Lewis L. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smeyne, Richard J., Charles B. Breckenridge, Melissa J. Beck, et al.. (2016). Assessment of the Effects of MPTP and Paraquat on Dopaminergic Neurons and Microglia in the Substantia Nigra Pars Compacta of C57BL/6 Mice. PLoS ONE. 11(10). e0164094–e0164094. 78 indexed citations
2.
Breckenridge, Charles B., Nicholas C. Sturgess, Mark T. Butt, et al.. (2013). Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice. NeuroToxicology. 37. 1–14. 36 indexed citations
3.
Styles, J.A., et al.. (2001). Tamoxifen mutagenesis and carcinogenesis in livers of lambda/lacI transgenic rats: selective influence of phenobarbital promotion. Cancer Letters. 162(1). 117–122. 12 indexed citations
4.
Smith, Lewis L., Karen Brown, P. Carthew, et al.. (2000). Chemoprevention of Breast Cancer by Tamoxifen: Risks and Opportunities. Critical Reviews in Toxicology. 30(5). 571–594. 70 indexed citations
5.
6.
Davies, Reginald, Victor Oreffo, S. C. Bayliss, et al.. (1996). Mutational specificity: Mutational spectra of tamoxifen-induced mutations in the livers oflacl transgenic rats. Environmental and Molecular Mutagenesis. 28(4). 430–433. 12 indexed citations
7.
Lock, Edward A., Martin K. Ellis, W. McLean Provan, et al.. (1996). Tissue Distribution of 2-(2-Nitro-4-trifluoromethylbenzoyl)cyclohexane-1,3-dione (NTBC): Effect on Enzymes Involved in Tyrosine Catabolism and Relevance to Ocular Toxicity in the Rat. Toxicology and Applied Pharmacology. 141(2). 439–447. 41 indexed citations
8.
Martin, Elizabeth A., et al.. (1995). 32P-Postlabelled DNA adducts in liver obtained from women treated with tamoxifen. Carcinogenesis. 16(7). 1651–1654. 74 indexed citations
9.
10.
Lim, Chang Kee, Zhi‐Xin Yuan, John H. Lamb, et al.. (1994). A comparative study of tamoxifen metabolism in female rat, mouse and human liver microsomes. Carcinogenesis. 15(4). 589–593. 92 indexed citations
11.
Styles, J.A., Adrian Davies, C.K. Lim, et al.. (1994). Genotoxicity of tamoxifen epoxide and toremifene in human lymphoblastoid cells containing human cytochrome P450s. Carcinogenesis. 15(1). 5–9. 101 indexed citations
12.
Lim, C.K., et al.. (1993). High performance liquid chromatography of tamoxifen and metabolites in plasma and tissues. Biomedical Chromatography. 7(6). 311–314. 19 indexed citations
13.
Matteis, Francesco De, Adrian Davies, Lewis L. Smith, et al.. (1992). Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cells. Carcinogenesis. 13(12). 2197–2203. 207 indexed citations
14.
O’Sullivan, Mary C., Bernard T. Golding, Lewis L. Smith, & I. Wyatt. (1991). Molecular features necessary for the uptake of diamines and related compounds by the polyamine receptor of rat lung slices. Biochemical Pharmacology. 41(12). 1839–1848. 26 indexed citations
15.
Smith, Lewis L., et al.. (1990). The importance of epithelial uptake systems in lung toxicity.. Environmental Health Perspectives. 85. 25–30. 24 indexed citations
16.
Risberg, Bo, Lewis L. Smith, M. H. Schoenberg, & Mamoun Younes. (1987). Lipid Peroxidation Is Not a Major Factor Involved in the Edema Formation in Perfused Lungs. European Surgical Research. 19(3). 164–170. 3 indexed citations
17.
O’Brien, Katherine, Lewis L. Smith, & Gerald M. Cohen. (1987). Inability of a human lung tumour cell line (A549) to detect chemically induced organ-specific toxicity to the lung. Toxicology in Vitro. 1(2). 85–90. 7 indexed citations
18.
Risberg, Bo, et al.. (1985). Prevention of Edema Formation in the Perfused Lung Preparation by Oxygen Radical Scavengers. European Surgical Research. 17(4). 230–236. 11 indexed citations
19.
Griffin, Martin, et al.. (1979). Changes in transglutaminase activity in an experimental model of pulmonary fibrosis induced by paraquat.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 60(6). 653–61. 65 indexed citations
20.
Rose, Michael S., Lewis L. Smith, & I. Wyatt. (1975). The accumulation of paraquat by the lung and the relevance of this to the treatment of paraquat poisoning. Toxicology and Applied Pharmacology. 33(1). 136. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dean J. Tuma Breakdown of academic impact, for papers by Hideki Mori Breakdown of academic impact, for papers by Naoki Yoshimi Breakdown of academic impact, for papers by Yoichi Konishi Breakdown of academic impact, for papers by Zhen Jiang Breakdown of academic impact, for papers by Kimihiko Satoh Breakdown of academic impact, for papers by Hideki Wanibuchi Breakdown of academic impact, for papers by Igor N. Zelko Breakdown of academic impact, for papers by Udayan Apte Breakdown of academic impact, for papers by Bhagavatula Moorthy
Rankless by CCL
2026